Navigation Links
NIH and NFL tackle concussion research
Date:12/16/2013

e affected by brain injury. Dr. Suskauer and her colleagues will investigate whether somatosensory system information processing (SSIP) could be used as a biomarker for concussion and recovery in youth aged 13-17. For these experiments, the researchers will use a new portable device that delivers vibrations to fingertips. Perception of the vibrations reflects activity of sensory neurons in the brain, thereby providing a measure of SSIP. The researchers will also investigate whether changes in SSIP are related to differences in certain brain chemicals after head injury.

  • Characterization of the Brain and Serum Metabolome in Mouse Models of Concussion
    Principal Investigator: Michael J. Whalen, M.D., Massachusetts General Hospital, Boston

    Metabolites are small molecules formed in the body as a result of the normal breakdown of proteins, drugs and other large molecules. The collection of all metabolites in the body is the metabolome. Studies have suggested that head injury may change levels of various brain byproducts, but this has not been researched in a systematic way. Dr. Whalen and his group plan to use an experimental model of traumatic brain injury to conduct a detailed analysis of changes in the brain metabolome following concussion. The researchers will compare those differences with serum byproducts to determine if the changes can be revealed in blood samples. The results of this project may uncover metabolites that contribute to serious effects of traumatic brain injury and may help identify potential targets for detecting and treating concussions.


    '/>"/>


  • Contact: Barbara McMakin
    nindspressteam@ninds.nih.gov
    301-496-5751
    NIH/National Institute of Neurological Disorders and Stroke
    Source:Eurekalert

    Page: 1 2 3 4 5 6 7

    Related biology news :

    1. Patients and scientists join forces to tackle Friedreichs Ataxia
    2. New textbook tackles the sustainable recycling of manure
    3. UCLA report urges new global policy effort to tackle crisis of plastic litter in oceans
    4. Transatlantic partnership to tackle neurodegenerative disease
    5. American Chemical Society global program tackles safe drinking water in Colombia
    6. Strengthening legumes to tackle fertilizer pollution
    7. After the Genome tackles tough questions about medicine, miracles and morality
    8. NTU scientist develops a multi-purpose wonder material to tackle enviromental challenges
    9. Penn conference tackles complex relationship between urbanization and food
    10. BGI and TGAC join efforts to tackle global challenges in food security, energy and health
    11. Fertilizers could help tackle nutritional deficiency in African country, researchers say
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/14/2014)... East Anglia have shown how the main psychoactive ingredient ... , Research published today reveals the existence of ... drug,s success in shrinking tumours. , It is ... equivalent with anti-cancer properties. , The research ... The team used samples of human breast cancer cells ...
    (Date:7/13/2014)... more effective treatments for cachexia, a profound wasting of ... cancer patients, raising their risk of death, according to ... been tried to reverse the condition, which may cause ... but none have had great success. , Scientists reporting ... Nature , led by Bruce Spiegelman, PhD, demonstrated that ...
    (Date:7/11/2014)... Mineral Research awarded Michael F. Holick, PhD, MD, of ... Louis V. Avioli Award. Holick, a professor of medicine, ... revolutionizing the understanding of vitamin D and its role ... member of the American Society for Bone and Mineral ... basic research. It is named for ASBMR,s first president ...
    Breaking Biology News(10 mins):UEA research reveals how cannabis compound could slow tumour growth 2Antibody halts cancer-related wasting condition 2Antibody halts cancer-related wasting condition 3BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2
    ... ON Physical activity is being increasingly recognized as ... Mammen,s review published in the October issue of the ... the connection one step further, finding that moderate exercise ... term. This is the first longitudinal review to ...
    ... Oct. 28, 2013  Aware, Inc. (NASDAQ: AWRE ), a ... for its third quarter ended September 30, 2013.  ... decrease of 15% compared to $5.3 million in the same quarter ... was $1.2 million, or $0.05 per diluted share, which compares to ...
    ... age of agriculture that began in the 1960s, potassium chloride ... widely used as a major fertilizer in the Corn Belt ... recognized for their fundamental importance to soil fertility. Three University ... approach to potassium management that has been in place for ...
    Cached Biology News:Aware, Inc. Reports Third Quarter 2013 Financial Results 2Aware, Inc. Reports Third Quarter 2013 Financial Results 3Aware, Inc. Reports Third Quarter 2013 Financial Results 4Aware, Inc. Reports Third Quarter 2013 Financial Results 5Study challenges soil testing for potassium and the fertilizer value of potassium chloride 2Study challenges soil testing for potassium and the fertilizer value of potassium chloride 3Study challenges soil testing for potassium and the fertilizer value of potassium chloride 4
    (Date:7/10/2014)... 2014 On July 9 Prime ... presented Russia,s first national "Industry" ... Company is developing a unique project called MabNext ... a number of innovative drugs based on monoclonal antibodies ... took place at the International Exhibition "Innoprom 2014" in ...
    (Date:7/10/2014)... , July 10, 2014 /PRNewswire-iReach/ -- ... and interpretation, today announced an agreement with ... analytics for Lineagen,s NextStep Dx PLUS.  ... neurodevelopmental and neurological disorders, currently offers FirstStep ... (CMA) testing service used by healthcare providers ...
    (Date:7/10/2014)... 2014   Ceres, Inc . (Nasdaq: ... today financial results for the three months ended May ... Ceres reported that the company and its ... growing season in Brazil, which concluded in June, despite ... evaluation areas for part of the growing season. Yields ...
    (Date:7/10/2014)... Adelaide research may help in the fight against terrorism ... tiny quantities of explosives with the use of light ... Sensors and Actuators B: Chemical , the researchers ... explosives in concentrations as low as 6.3 ppm (parts ... a few minutes. , "Traditionally explosives detection has involved ...
    Breaking Biology Technology:Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9Detecting trace amounts of explosives with light 2
    ... Tengion, Inc. (NASDAQ: TNGN ), a leader ... the Company,s Neo-Urinary Conduit™ (NUC) and Neo-Kidney Augment™ (NUC) ... North America Annual Conference being held December 11-14, in ... further supported by various cellular and molecular studies demonstrating ...
    ... Pharma Inc. (Tokyo: 4503, Astellas) and Ambit Biosciences Corporation ... of a Phase 2 study of quizartinib (formerly AC220) ... 53rd Annual Meeting of the American Society of Hematology ... from two additional posters: one evaluating the pharmacodynamic effects ...
    ... 13, 2011 Tarsa Therapeutics today confirmed that it ... to the Food and Drug Administration (FDA) in the ... recombinant salmon calcitonin tablet for the treatment of postmenopausal ... that verified the results from Tarsa,s Phase III ORACAL ...
    Cached Biology Technology:Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 2Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 3Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 2Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 3Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 4Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 5Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 6Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 7Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society 8Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 2Tarsa Therapeutics Targets 2012 NDA Submission for its OSTORA™ Oral Calcitonin 3
    Oven mesh sheets, large, 23 x 23cm, pack of 5...
    ... Phosphatase ( l-PPase) is ... with activity towards phosphorylated ... residues. It is the ... the ORF221 open reading ...
    ... is a high performance spectral scanning ... incubator. With the advanced SkanIt Software ... for drug discovery assay development. Varioskan ... intensity, time-resolved fluorescence and photometric assays ...
    ... refrigerated cold traps offers a choice of ... solvents or high volatility solvents. Ideal to ... evaporators. Also used for maintaining vapor-free gas ... in electron microscopes. Can be used as ...
    Biology Products: